NCT04412824

Brief Summary

This study proposes to examine both the peripheral and central nervous system responses when light social drinkers and binge/heavy social drinkers are exposed to visual ethanol cues, followed by oral ethanol. The findings will provide a greater understanding of the brain mechanisms (cerebral blood flow and functional connectivity) underlying the association between stress, cortisol release, alcohol craving, and alcohol stimulant and sedative effects. This knowledge could be significant in developing new therapies for the treatment of alcoholism.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
87

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 22, 2020

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

May 24, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 2, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

March 22, 2022

Status Verified

March 1, 2022

Enrollment Period

1.6 years

First QC Date

May 24, 2020

Last Update Submit

March 19, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in Neural Blood Flow

    Blood flow is measured in ml/100 grams/minute. The interpretation is that blood flow to that area indicates that region of the brain is responding to the visual alcohol or non-alcoholic beverage cues. Change in blood flow will be calculated as the change (and slope) of measurements taken at 10, 20, 30 and 45 minutes during the procedure.

    During the Procedure: measurements taken at 10, 20, 30 and 45 minutes during the procedure.

  • Change in Cortisol

    The units for cortisol are micrograms/deciliter and the interpretation is that amount has been released into the blood stream from the HPA axis in response to alcohol or alcohol cues. Change in Cortisol will be calculated by taking the change (and slopes) of measurements at 45, 30 and 5 minutes prior to procedure and comparing it to measurements taken at 65, 95, 110, 125 minutes following the procedure.

    Before Procedure to 125 minutes after the procedure.

  • Drinking Behavior in daily experience outside of laboratory

    A smartphone app will be used to collect 4 surveys a day for 30 days after completion of both arms. Multilevel modeling will be used to analyze patterns of drinking over time.

    Day after Procedure to 30 days after procedure.

  • Amount of Alcohol Consumed

    After exposure to alcoholic beverage and non-alcoholic beverage visual cues, quantity of alcohol consumed in a free choice test will be measured in milliliters.

    Immediately after the procedure.

Secondary Outcomes (3)

  • Changes in Alcohol Urges (AUQ)

    Before Procedure to 125 minutes after the procedure.

  • Stress levels in daily experience outside of laboratory

    Post follow-up procedure (30 days)

  • Genetic Risk Factors (Single Nucleotide Polymorphisms; SNPs) Association with Cerebral Blood Flow, Craving, and Real world drinking and stress

    Post follow up procedure (within 2 years after procedure)

Study Arms (2)

Alcohol Beverage Cues

ACTIVE COMPARATOR

Participants will complete an MRI with alcohol beverage visual cues and oral alcohol session.

Drug: Intravenous blood draw

Non-Alcoholic Beverage Cues

PLACEBO COMPARATOR

Participants will complete an MRI with non-alcoholic beverage cues and oral alcohol session.

Drug: Intravenous blood draw

Interventions

In addition to the oral delivery, an IV line will be placed for the purpose of drawing blood during the MRI session

Also known as: Indwelling catheter for blood draws
Alcohol Beverage CuesNon-Alcoholic Beverage Cues

Eligibility Criteria

Age21 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Binge/Heavy Social Drinkers (HSD): has never met DSM-IV criteria for alcohol or substance dependence; regular alcohol use over the past year of at least 10 drinks per week, including at lease one occasion per week consuming \>4 drinks (males) or \>3 drinks (females).
  • Able to read and write English.
  • Light Social Drinkers (LSD): has never met DSM-IV criteria for alcohol or substance dependence; regular alcohol use over the past year of 1-3 drinks per occasion, 1-3 times weekly, with no more than one occasion per month of drinking \>4 drinks (male) or \>3 drinks (females) (King et al., 2002).
  • Do not meet criteria for any Axis I DSM-IV psychiatric diagnoses except for individuals with a past diagnosis of Post-Traumatic Stress Disorder, Major Depressive Disorder, or Obsessive Compulsive Disorder
  • Provide negative urine toxicology screens during initial appointments and at admission for IV/fMRI sessions.
  • Body Mass Index between 20-35.
  • No current or former nicotine dependence.

You may not qualify if:

  • Meet current criteria for dependence on any psychoactive substance, excluding caffeine.
  • Current or past history of alcohol dependence or abuse.
  • Any current use of opiates or past history of opiate abuse/dependence.
  • Current use of any psychoactive drugs, including anxiolytics, antidepressants, naltrexone or antabuse.
  • Any psychotic disorder or current psychiatric symptoms requiring specific attention, including need for psychiatric medications for current major depression and anxiety disorders.
  • Any significant current medical condition such as neurological, cardiovascular, endocrine, renal, liver, thyroid pathology; subjects on medications for any medical condition will be excluded.
  • Peri and post-menopausal women, and those with hysterectomies.
  • Pregnant and lactating women will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Auburn University MRI Center

Auburn, Alabama, 36832, United States

Location

Related Publications (1)

  • Blaine SK, Ridner CM, Campbell BR, Crone L, Claus ED, Wilson JR, West SN, McClanahan AJ, Siddiq AS, Layman IMP, Macatee R, Ansell EB, Robinson JL, Beck DT. IL-6, but not TNF-alpha, response to alcohol cues and acute consumption associated with neural cue reactivity, craving, and future drinking in binge drinkers. Brain Behav Immun Health. 2023 Jun 11;31:100645. doi: 10.1016/j.bbih.2023.100645. eCollection 2023 Aug.

MeSH Terms

Conditions

Alcoholism

Interventions

Catheters, IndwellingBlood Specimen Collection

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

CathetersEquipment and SuppliesSpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Sara K Blaine, PhD

    Auburn University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professsor

Study Record Dates

First Submitted

May 24, 2020

First Posted

June 2, 2020

Study Start

May 22, 2020

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

March 22, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

HIPAA requirements prohibit sharing of individual data. De-identified group data will be available.

Locations